Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Pharmacokinetics of n-propyl-ajmaline-bitartrate in elderly patients with ventricular ectopic activity

  • 11 Accesses

  • 2 Citations

Summary

11 patients (9m, 2f, median age 59 years) with ventricular ectopic activity of at least Lown grade III received 20 mg N-Propylajmaline-bitartrate (N-PAB)* p.o. Plasma concentrations of N-PAB were determined with HPLC from blood samples within 26 hours after administration. An open two-compartment model was used. In 8 patients with normal function of the liver and the kidneys, the median clearance of N-PAB was 6.86 ml/min/kg and the median volume of distribution was 1.56 1/kg. Two patients had a clearly diminished clearance of 1.58 ml/min/kg without obvious impairment of liver or renal function. One patient with chronic glomerulonephritis (plasma creatinine 3.4 mg/dl) had a N-PAB clearance of 2.79 ml/min/kg. None of the Spearman rank correlation coefficients between the pharmacokinetic parameters of N-PAB with age, plasma albumin, albumin/globulin-quotient, plasma creatinine and cholin-esterase were significant. All calculated parameters were in the range determined in young subjects. It is concluded that physiological changes with age do not lead to significant changes of the pharmacokinetics of N-PAB. On the other hand in patients with increased levels of plasma creatinine a diminished clearance of N-PAB can be expected. It is also possible that patients without an obvious impairment of liver or renal function may have diminished N-PAB clearance.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Holloway D.A. (1974): Drug problems in the geriatric patient. Drug Intel Clin Pharm8, 632–642.

  2. 2.

    Hurwitz N. (1969): Predisposing factors in adverse reactions to drugs. Br Med. J.1, 536–539.

  3. 3.

    Crooks J., O’Malley K., Stevenson I.H. (1976): Pharmacokinetics in the elderly. Clin Pharmacokinet1, 280–296.

  4. 4.

    Triggs E.J. (1975): Pharmacokinetics in the aged: a review. J. Pharmacokinet Biopharm3, 387–418.

  5. 5.

    Vestal R.E. (1978): Drug use in the elderly: a review of problems and special considerations. Drugs16, 358–382.

  6. 6.

    Hausleiter H. J., Achten G., Khan M.A., Kukovetz W.R., Beubler E. (1982): Pharmacokinetik und Biotransformation von N-Propyl-ajmalinhydrogentartrat beim Menschen. Eur. J. Drug. Metab. Pharmacokinet7, 329–339.

  7. 7.

    Zekorn C, Achtelt G., Hausleiter H.J., Moon C.H., Eichelbaum M. (1985): Pharmacokinetics of N-Propylajmaline in relation to polymorphic sparteine oxidation. Klin. Wochenschr.63, 1180–1186.

  8. 8.

    Grundevik I., Persson B.A. (1982): Assay of N-propylajmaline in blood plasma by Ion-pair-liquid-liquid chromatography. J. Liqu. Chromatogr.5, 141–150.

  9. 9.

    SAS User’s guide: statistics. (1982): SAS Institute North Carolina.

  10. 10.

    Wagner J.G. (1979): Fundamentals of clinical pharmacokinetics. Drug Intelligence Publications Illinois.

  11. 11.

    Kiechel J.R. (1982): Biotransformation of drugs during aging. Gerontology 28 (Suppl. 1), 101–112.

  12. 12.

    Shand D.G. (1982): Biological determinants of altered pharmacokinetics in the elderly. Gerontology 28 (Suppl. 1), 8–17.

  13. 13.

    Bender A.D. (1965): Effect of increasing age on the distribution of peripheral blood flow in man. J. Am. Geriat Soc.13, 192–198.

  14. 14.

    Bender A.D. (1968): Effect of age on intestinal absorption. J. Am. Geriat Soc.16, 1331–1339.

  15. 15.

    Novak L.P. (1972): Aging, total body potassium, fat-free mass and all mass in males and females between ages 18 and 85 years. J. Geront.27, 438–443.

  16. 16.

    Vestal R.E., Norris A.H., Tobin J.D., Cohen B.H., Shock N.W., Andres R. (1975): Antipyrine metabolism in man: influence of age, alcohol, caffeine and smoking. Clin. Pharmacol. Ther.18, 425–432.

  17. 17.

    Woodford-Williams E., Alvarez D., Webster B., Kandless B., Dixon M.P. (1964): Serum protein patterns in normal and pathological aging. Gerontologica10, 86–99.

  18. 18.

    Klotz U., Avant G.R., Hoyumpa A., Schenker S., Wilkinson G.R. (1975): The effect of age and liver disease on the disposition and elimination of diazepam in adult man. J. Clin. Invest.55, 347–359.

  19. 19.

    Shader R.I., Greenblatt D.J., Harmatz J.S., Frank K., Koch-Weser J. (1977): Absorption and disposition of chlordiazepoxide in young and elderly male volunteers. J. Clin. Pharmacol.17, 709–718.

  20. 20.

    Lisalo E., Kangas L., Selig M. (1977): Pharmacokinetics of nitrazepam in young volunteers and aged patients. Br. J. Clin. Pharmacol.4, 646–647.

  21. 21.

    Nation R.L., Triggs E.J., Selig M. (1977): Lignocaine kinetics in cardiac patients and aged subjects. Br. J. Clin. Pharmacol.4, 439–448.

  22. 22.

    O’Malley K., Crooks J., Duke E., Stevenson I.H. (1971): Effect of age and sex on human drug metabolism. Br. Med. J.11, 607–609.

  23. 23.

    Hewick D.S., Moreland T.A., Shepherd AMM., Stevenson I.H. (1975): The effect of age on the sensitivity to warfarin sodium. Br. J. Clin. Pharmacol.2, 189–190P.

  24. 24.

    Kato R., Takanaka A. (1968): Metabolism of drugs in old rats. Jap. J. Pharmacol.18, 381–388.

  25. 25.

    Bach B., Hansen J.M., Kampmann J.P., Rasmussen S.N., Skovsted L. (1981): Disposition of antipyrine and Phenytoin correlated with age and liver volume in man. Clin. Pharmacokinet.6, 389–396.

  26. 26.

    Rowe J.W., Andres R., Tobin J.D., Norris A.H., Shock N.W. (1976): The effect of age on creatinine clearance in man: a cross-sectional and longitudinal study. J. Geront.31, 155–163.

  27. 27.

    Schramm A., Jenett M., Gerhardt K.H. (1981): Veränderungen der Nierenfunktion und -morphologie im Alter. Z. Geront.14, 354–369.

  28. 28.

    Ochs Hr., Greenblatt D.J., Woo E., Smith T.W. (1978): Reduced quinidine clearance in elderly patients. Am. J. Cardiol.42, 481–485.

  29. 29.

    Haasis R., Mikulla A., Roth W. (1980): Klinische Studie zur Interaktion zwischen Prajmaliumbitartrat und β-Methyldigoxin. Med. Welt.43, 883–888.

Download references

Author information

Correspondence to R. Elfner.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Elfner, R., Achtert, G., Hausleiter, H.J. et al. Pharmacokinetics of n-propyl-ajmaline-bitartrate in elderly patients with ventricular ectopic activity. European Journal of Drug Metabolism and Pharmacokinetics 12, 77–82 (1987). https://doi.org/10.1007/BF03189865

Download citation

Key words

  • N-Propyl-ajmaline-bitartrate
  • (N-PAB) pharmacokinetics
  • elderly
  • metabolism